BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 4181510)

  • 41. Association of the long-acting thyroid stimulator protector with the immunoglobulin G fraction of serum from patients with thyrotoxicosis.
    Dirmikis SM; Justice SK; Munro DS
    Biochim Biophys Acta; 1975 Jan; 379(1):239-46. PubMed ID: 1115798
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [TSH-receptor-bound antithyroid antibody and the etiology of Basedow's disease].
    Shishiba Y
    Nihon Rinsho; 1983; 41(4):801-7. PubMed ID: 6310180
    [No Abstract]   [Full Text] [Related]  

  • 43. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
    [No Abstract]   [Full Text] [Related]  

  • 44. Interaction of purified long-acting thyroid stimulator (LATS) and thyroid microsomes in vitro.
    Wong ET; Litman GW
    J Clin Endocrinol Metab; 1969 Jan; 29(1):72-8. PubMed ID: 5762323
    [No Abstract]   [Full Text] [Related]  

  • 45. Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates.
    Mehdi SQ; Badger J; Kriss JP
    Endocrinology; 1977 Jul; 101(1):59-65. PubMed ID: 193685
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of long-acting thyroid stimulator by thyroid particulate fractions.
    Beall GN; Solomon DH
    J Clin Invest; 1966 Apr; 45(4):552-61. PubMed ID: 5937026
    [No Abstract]   [Full Text] [Related]  

  • 47. Failure of long-acting thyroid stimulator globulin (LATS) and serum to stimulate thyroid function in the chick.
    Lepp A; Oliner L
    Endocrinology; 1967 Feb; 80(2):369-74. PubMed ID: 4163488
    [No Abstract]   [Full Text] [Related]  

  • 48. [Behavior of antithyroglobulin and antimicrosomal antibodies in thyroid pathology].
    Sussi PL; Burro A; Plebani M; Abrescia F; Perazzolo E; Petronio R
    Chir Ital; 1984 Aug; 36(4):643-7. PubMed ID: 6549274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. On the interaction of long-acting thyroid stimulator with thyroid microsomes.
    Burke G
    J Clin Endocrinol Metab; 1967 Aug; 27(8):1095-102. PubMed ID: 4166580
    [No Abstract]   [Full Text] [Related]  

  • 50. [Extent of the manifestation of autoimmune disorders in thyrotoxicosis patients in localities endemic for goiter].
    Epishin AV
    Vrach Delo; 1983 Apr; (4):61-4. PubMed ID: 6868539
    [No Abstract]   [Full Text] [Related]  

  • 51. Thyroid autoantibodies in thyroid disease.
    Rose NR; Witebsky E
    Adv Metab Disord; 1968; 3():231-77. PubMed ID: 4973548
    [No Abstract]   [Full Text] [Related]  

  • 52. [Demonstration of immunoglobulins on the cytoplasmic membrane of living cells isolated from basedowian thyroid glands].
    Indiveri F; Barabino A; Rolandi E; Masturzo P; Azzolini A
    Boll Soc Ital Biol Sper; 1973 Nov; 49(21):1197-201. PubMed ID: 4605604
    [No Abstract]   [Full Text] [Related]  

  • 53. A STANDARD FOR THE LONG-ACTING THYROID STIMULATOR (LATS) IN THE SERUM OF PATIENTS WITH THYROTOXICOSIS.
    DORRINGTON KJ; MUNRO DS
    J Endocrinol; 1964 Nov; 31():21-8. PubMed ID: 14231127
    [No Abstract]   [Full Text] [Related]  

  • 54. [Cytogenetic studies in patients with thyroiditis and LATS and antibody-positive hyperthyroidism].
    Tolksdorf M; Schemmel K; Mühlenstedt D; Uthgenannt H; Müller W
    Schweiz Med Wochenschr; 1969 Jul; 99(30):1082-5. PubMed ID: 5351142
    [No Abstract]   [Full Text] [Related]  

  • 55. [Absent biological demonstration of "long-acting thyroid stimulator" (LATS) in endemic euthyroid iodine deficiency goiters].
    Stelzer M; Mertz DP
    Munch Med Wochenschr; 1969 Jun; 111(23):1306-9. PubMed ID: 5820134
    [No Abstract]   [Full Text] [Related]  

  • 56. Humoral immunity and autoimmune disease.
    Roitt IM
    Vox Sang; 1969 Apr; 16(4):341-4. PubMed ID: 4184411
    [No Abstract]   [Full Text] [Related]  

  • 57. Concentration of long-acting thyroid stimulator (LATS) by subfractionation of gamma G globulin from Graves' disease serum.
    Miyai K; Werner SC
    J Clin Endocrinol Metab; 1966 May; 26(5):504-12. PubMed ID: 5952570
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies on the nature of plasma thyroid stimulating activity in hyperthyroidism.
    Hoffman MJ; Mason EK; Good BF; Hetzel BS; Ferguson K
    Australas Ann Med; 1967 May; 16(2):98-106. PubMed ID: 4167406
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunological features of nonimmunogenic hyperthyroidism.
    Grubeck-Loebenstein B; Derfler K; Kassal H; Knapp W; Krisch K; Liszka K; Smyth PP; Waldhäusl W
    J Clin Endocrinol Metab; 1985 Jan; 60(1):150-5. PubMed ID: 2856880
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical studies on thyroid autoantibodies in the blood in thyroid diseases. 1. Autoantibodies in the blood in thyroid diseases].
    Hara M
    Nihon Naibunpi Gakkai Zasshi; 1966 Nov; 42(8):918-33. PubMed ID: 6008358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.